Publication | Closed Access

Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients

MedicinePharmacologyCapecitabine PharmacokineticsCarboxylesterase 1PharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer Research